Novo Pays Up to $1.3 Billion for Nanexa's Drug Delivery Tech

Novo Nordisk NYSE:NVO shares were unchanged in Copenhagen after the company signed a global exclusive license and collaboration deal worth up to 1.165 billion ($1.3 billion) with Nanexa, a Swedish drug delivery company. Nanexa's Stockholm-listed shares more than doubled in early Friday trading.The…